Promoter polymorphism in the 5-lipoxygenase (ALOX5) and 5-lipoxygenase-activating protein (ALOX5AP) genes and asthma susceptibility in a Caucasian population
Promoter polymorphism in the 5-lipoxygenase (ALOX5) and 5-lipoxygenase-activating protein (ALOX5AP) genes and asthma susceptibility in a Caucasian population
Background: 5-Lipoxygenase (5-LO) and 5-lipoxygenase-activating protein (FLAP) are essential for cysteinyl-leukotriene (cys-LT) production, critical mediators in asthma.
Objective: We sought to identify novel promoter polymorphisms within the FLAP (ALOX5AP) gene promoter and test the role of these and the previously identified 5-LO (ALOX5) Sp1 promoter polymorphism in asthma susceptibility.
Methods: To assess genetic association with asthma phenotypes, we genotyped 341 Caucasian families (containing two asthmatic siblings) and non-asthmatic control subjects (n=184). Genetic association was determined by case–control and transmission disequilibrium test (TDT) analyses. To determine the functional role of polymorphisms on basal transcription, we generated ALOX5AP-promoter-luciferase constructs and transiently transfected human HeLa cells.
Results: A novel G/A substitution at –336 bp and a poly(A) repeat (n=19 or 23) at position ?169 to ?146 bp were identified in the ALOX5AP promoter. Genotyping found the ?336 A and poly(A19) alleles at frequencies of q=0.06 and 0.12, respectively. No ALOX5AP allele was associated with asthma or asthma-related phenotypes in case–control or TDT analyses. ALOX5AP-promoter-luciferase analyses did not support a functional role of the ?336 or poly(A) polymorphism in determining basal transcription. The ALOX5 Sp1 polymorphism was predominantly homozygous wild-type 5/5 (frequency q=0.70) and heterozygous 4/5 (q=0.23) genotypes and no allele was associated with asthma or asthma-related phenotypes.
Conclusion: Taken together, these data do not support a significant role for these polymorphisms in genetic susceptibility to asthma in the Caucasian population.
1103-1110
Sayers, I.
230e01df-0685-438a-9173-df1aead72390
Barton, S.
4f674382-ca0b-44ad-9670-e71a0b134ef0
Rorke, S.
ca4b3d19-8862-40e7-8f33-b20da825b08d
Sawyer, J.
262b1470-8d4f-43a6-bf72-e1d2c53d8448
Peng, Q.
ca0f24d6-e072-44d9-89ff-6f6d80b0c91e
Beghe, B.
d4335e8e-fd57-41e3-9d71-69c0886bf145
Ye, S.
73027825-861c-4bca-8ce6-67a325fa2d2c
Keith, T.
763038f9-17c3-4e83-b7a1-3fd562b87a66
Clough, J.B.
54c3712a-f495-4ba6-b190-73fa0ba2b30f
Holloway, J.W.
4bbd77e6-c095-445d-a36b-a50a72f6fe1a
Sampson, A.P.
4ca76f6f-ff35-425d-a7e7-c2bd2ea2df60
Holgate, S.T.
2e7c17a9-6796-436e-8772-1fe6d2ac5edc
2003
Sayers, I.
230e01df-0685-438a-9173-df1aead72390
Barton, S.
4f674382-ca0b-44ad-9670-e71a0b134ef0
Rorke, S.
ca4b3d19-8862-40e7-8f33-b20da825b08d
Sawyer, J.
262b1470-8d4f-43a6-bf72-e1d2c53d8448
Peng, Q.
ca0f24d6-e072-44d9-89ff-6f6d80b0c91e
Beghe, B.
d4335e8e-fd57-41e3-9d71-69c0886bf145
Ye, S.
73027825-861c-4bca-8ce6-67a325fa2d2c
Keith, T.
763038f9-17c3-4e83-b7a1-3fd562b87a66
Clough, J.B.
54c3712a-f495-4ba6-b190-73fa0ba2b30f
Holloway, J.W.
4bbd77e6-c095-445d-a36b-a50a72f6fe1a
Sampson, A.P.
4ca76f6f-ff35-425d-a7e7-c2bd2ea2df60
Holgate, S.T.
2e7c17a9-6796-436e-8772-1fe6d2ac5edc
Sayers, I., Barton, S., Rorke, S., Sawyer, J., Peng, Q., Beghe, B., Ye, S., Keith, T., Clough, J.B., Holloway, J.W., Sampson, A.P. and Holgate, S.T.
(2003)
Promoter polymorphism in the 5-lipoxygenase (ALOX5) and 5-lipoxygenase-activating protein (ALOX5AP) genes and asthma susceptibility in a Caucasian population.
Clinical & Experimental Allergy, 33 (8), .
(doi:10.1046/j.1365-2222.2003.01733.x).
Abstract
Background: 5-Lipoxygenase (5-LO) and 5-lipoxygenase-activating protein (FLAP) are essential for cysteinyl-leukotriene (cys-LT) production, critical mediators in asthma.
Objective: We sought to identify novel promoter polymorphisms within the FLAP (ALOX5AP) gene promoter and test the role of these and the previously identified 5-LO (ALOX5) Sp1 promoter polymorphism in asthma susceptibility.
Methods: To assess genetic association with asthma phenotypes, we genotyped 341 Caucasian families (containing two asthmatic siblings) and non-asthmatic control subjects (n=184). Genetic association was determined by case–control and transmission disequilibrium test (TDT) analyses. To determine the functional role of polymorphisms on basal transcription, we generated ALOX5AP-promoter-luciferase constructs and transiently transfected human HeLa cells.
Results: A novel G/A substitution at –336 bp and a poly(A) repeat (n=19 or 23) at position ?169 to ?146 bp were identified in the ALOX5AP promoter. Genotyping found the ?336 A and poly(A19) alleles at frequencies of q=0.06 and 0.12, respectively. No ALOX5AP allele was associated with asthma or asthma-related phenotypes in case–control or TDT analyses. ALOX5AP-promoter-luciferase analyses did not support a functional role of the ?336 or poly(A) polymorphism in determining basal transcription. The ALOX5 Sp1 polymorphism was predominantly homozygous wild-type 5/5 (frequency q=0.70) and heterozygous 4/5 (q=0.23) genotypes and no allele was associated with asthma or asthma-related phenotypes.
Conclusion: Taken together, these data do not support a significant role for these polymorphisms in genetic susceptibility to asthma in the Caucasian population.
This record has no associated files available for download.
More information
Published date: 2003
Identifiers
Local EPrints ID: 24938
URI: http://eprints.soton.ac.uk/id/eprint/24938
ISSN: 0954-7894
PURE UUID: 19030410-930d-4e13-a6c6-e79b2017f52e
Catalogue record
Date deposited: 06 Apr 2006
Last modified: 16 Mar 2024 03:22
Export record
Altmetrics
Contributors
Author:
I. Sayers
Author:
S. Rorke
Author:
J. Sawyer
Author:
Q. Peng
Author:
B. Beghe
Author:
S. Ye
Author:
T. Keith
Author:
J.B. Clough
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics